Title : Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway.

Pub. Date : 2019 Sep

PMID : 31233204






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 In addition, expression of inflammatory response-related genes was increased, while secretion of angiogenesis-related molecules was decreased, and apoptosis was also activated after sorafenib treatment using qPCR method, and it was further demonstrated that this effect was mediated by inhibition of the PI3K/AKT/mTOR/ERK signaling pathway using western blot analysis. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 In conclusion, overexpression of BRMS1 potentiated the effect of sorafenib via PI3K/AKT/mTOR/ERK signaling, while knockdown of BRMS1 expression attenuated this effect. Sorafenib AKT serine/threonine kinase 1 Homo sapiens